Red Cell Therapeutics - Providence Business News

Home Tags Red Cell Therapeutics

RUBIUS THERAPEUTICS has secured a $75M loan from Solar Capital Partners to advance its Red Cell Therapeutics line. The company does not yet generate revenue.

Rubius: $75M loan will fund research, operations through 2021

Health Services 12/26/2018

PROVIDENCE – Cambridge, Mass.-headquartered biotechnology firm Rubius Therapeutics Inc. has secured a $75 million loan from Solar Capital Partners to advance its Red Cell...

- Featured Event -

Latest News

RIDOT gets $13.5M for Providence ferry terminal upgrades

08/18/2026

Medeiros steps down as Kent County YMCA executive director

08/18/2026

McKee urges statewide pause of Flock cameras, calls for review

08/18/2026

Michael Kapos named CEO of Downeast Coffee

08/18/2026

Federal judge clears path for R.I. cannabis retail license process to...

08/18/2026

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.